In chronic myeloid leukaemia, it has been shown that expression of the p210 BCR-ABL fusion protein leads to a downregulation of BRCA1 protein expression, owing to post-transcriptional mechanisms (Deutsch et al, 2003). Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.